KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Bristol Myers Squibb (BMY) Accumulated Depreciation & Amortization (2016 - 2026)

Bristol Myers Squibb has reported Accumulated Depreciation & Amortization over the past 18 years, most recently at $594.0 million for Q1 2026.

  • Quarterly Accumulated Depreciation & Amortization fell 41.3% to $594.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $594.0 million through Mar 2026, down 41.3% year-over-year, with the annual reading at $4.0 billion for FY2025, 58.22% down from the prior year.
  • Accumulated Depreciation & Amortization was $594.0 million for Q1 2026 at Bristol Myers Squibb, down from $4.0 billion in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $10.3 billion in Q4 2022 and troughed at $594.0 million in Q1 2026.
  • The 5-year median for Accumulated Depreciation & Amortization is $4.9 billion (2023), against an average of $5.0 billion.
  • Year-over-year, Accumulated Depreciation & Amortization grew 5.81% in 2024 and then tumbled 60.7% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $10.3 billion in 2022, then decreased by 5.02% to $9.8 billion in 2023, then fell by 1.64% to $9.6 billion in 2024, then tumbled by 58.22% to $4.0 billion in 2025, then plummeted by 85.19% to $594.0 million in 2026.
  • Per Business Quant, the three most recent readings for BMY's Accumulated Depreciation & Amortization are $594.0 million (Q1 2026), $4.0 billion (Q4 2025), and $3.0 billion (Q3 2025).